Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Hosp Infect ; 114: 117-125, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33930487

RESUMEN

BACKGROUND: Healthcare workers (HCWs) are at the front line of the ongoing coronavirus 2019 (COVID-19) pandemic. Comprehensive evaluation of the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among HCWs in a large healthcare system could help to identify the impact of epidemiological factors and the presence of symptoms on the immune response to the infection over time. AIM: To determine the seroprevalence of SARS-CoV-2-specific antibodies among HCWs, identify associated epidemiological factors and study antibody kinetics. METHODS: A longitudinal evaluation of the seroprevalence and epidemiology of SARS-CoV-2-specific antibodies was undertaken in approximately 30,000 HCWs in the largest healthcare system in Connecticut, USA. FINDINGS: At baseline, the prevalence of SARS-CoV-2 antibody among 6863 HCWs was 6.3% [95% confidence interval (CI) 5.7-6.9%], and was highest among patient care support (16.7%), medical assistants (9.1%) and nurses (8.2%), and lower for physicians (3.8%) and advanced practice providers (4.5%). Seroprevalence was significantly higher among African Americans [odds ratio (OR) 3.26 compared with Caucasians, 95% CI 1.77-5.99], in participants with at least one symptom of COVID-19 (OR 3.00, 95% CI 1.92-4.68), and in those reporting prior quarantine (OR 3.83, 95% CI 2.57-5.70). No symptoms were reported in 24% of seropositive participants. Among the 47% of participants who returned for a follow-up serological test, the seroreversion rate was 39.5% and the seroconversion rate was 2.2%. The incidence of re-infection in the seropositive group was zero. CONCLUSION: Although there is a decline in the immunoglobulin G antibody signal over time, 60.5% of seropositive HCWs had maintained their seroconversion status after a median of 5.5 months.


Asunto(s)
Anticuerpos Antivirales/sangre , COVID-19 , SARS-CoV-2 , Adulto , COVID-19/inmunología , Connecticut/epidemiología , Femenino , Personal de Salud , Humanos , Cinética , Masculino , Persona de Mediana Edad , SARS-CoV-2/inmunología , Estudios Seroepidemiológicos
3.
Surg Endosc ; 19(4): 541-5, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15742125

RESUMEN

BACKGROUND: Pneumoperitoneum has been associated with a decreased flow in the superior mesenteric artery and portal venous system. Intestinal blood flow was studied during a 2-h pneumoperitoneum with carbon dioxide (CO2) or helium in a porcine model using colored microspheres. METHODS: For this study, 12 pigs were divided into two groups (6 CO2 and 6 helium). Different colored microspheres were injected directly into the left ventricle before, 40, 80, and 120 min after insufflation with either gas at a pressure of 15 mmHg. Microsphere concentration was measured in the mucosa and muscularis/serosa layers of the jejunum, cecum, and sigmoid colon to calculate blood flow. RESULTS: Intestinal perfusion initially increases with insufflation and returns to near baseline levels during pneumoperitoneum of 2 h. The effect of helium on tissue perfusion is similar to that of carbon dioxide. CONCLUSIONS: Intestinal perfusion does not change significantly during prolonged pneumoperitoneum at a pressure of 15 mmHg with CO2 or helium.


Asunto(s)
Dióxido de Carbono/farmacología , Helio/farmacología , Intestinos/irrigación sanguínea , Neumoperitoneo Artificial , Animales , Velocidad del Flujo Sanguíneo , Dióxido de Carbono/administración & dosificación , Gasto Cardíaco , Ciego/irrigación sanguínea , Colon Sigmoide/irrigación sanguínea , Frecuencia Cardíaca , Helio/administración & dosificación , Insuflación , Mucosa Intestinal/irrigación sanguínea , Isquemia/etiología , Isquemia/fisiopatología , Yeyuno/irrigación sanguínea , Microesferas , Músculo Liso/irrigación sanguínea , Neumoperitoneo Artificial/efectos adversos , Neumoperitoneo Artificial/métodos , Presión , Sus scrofa
4.
Surg Endosc ; 19(5): 628-32, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15759176

RESUMEN

BACKGROUND: Gastrojejunal strictures following laparoscopic Roux-en-Y gastric bypass (LRYGBP) present with dysphagia, nausea, and vomiting. Diagnosis is made by endoscopy and/or radiographic studies. Therapeutic options include endoscopic dilation and surgical revision. METHODS: Of 369 LRYGBP performed, 19 patients developed anastomotic stricture (5.1%). One additional patient was referred from another facility. Pneumatic balloons were used for initial dilation in all patients. Savary-Gilliard bougies were used for some of the subsequent dilations. RESULTS: Flexible endoscopy was diagnostic in all 20 patients allowing dilation in 18 (90%). Two patients did not undergo endoscopic dilation because of anastomotic obstruction and ulcer. The median time to stricture development was 32 days (range: 17-85). Most patients (78%) required more than two dilations. The complication rate was 1.6% (one case of microperforation). At a mean follow-up of 21 months, all patients were symptom-free. CONCLUSIONS: Gastrojejunostomy stricture following LRYGBP is associated with substantial morbidity and patient dissatisfaction. Based on our experience, we propose a clinical grading system and present our strategy for managing gastrojejunal strictures.


Asunto(s)
Derivación Gástrica , Enfermedades del Yeyuno/etiología , Laparoscopía , Obesidad Mórbida/cirugía , Complicaciones Posoperatorias/etiología , Gastropatías/etiología , Adulto , Anciano , Cateterismo , Constricción Patológica/epidemiología , Constricción Patológica/etiología , Trastornos de Deglución/epidemiología , Trastornos de Deglución/etiología , Dilatación , Endoscopía Gastrointestinal , Femenino , Estudios de Seguimiento , Derivación Gástrica/métodos , Derivación Gástrica/psicología , Humanos , Enfermedades del Yeyuno/diagnóstico , Enfermedades del Yeyuno/epidemiología , Enfermedades del Yeyuno/psicología , Enfermedades del Yeyuno/cirugía , Laparoscopía/métodos , Laparoscopía/psicología , Masculino , Persona de Mediana Edad , Satisfacción del Paciente , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/psicología , Complicaciones Posoperatorias/cirugía , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Gastropatías/diagnóstico , Gastropatías/epidemiología , Gastropatías/psicología , Gastropatías/cirugía , Úlcera Gástrica/diagnóstico , Úlcera Gástrica/epidemiología , Úlcera Gástrica/etiología , Úlcera Gástrica/psicología , Úlcera Gástrica/cirugía , Engrapadoras Quirúrgicas , Técnicas de Sutura , Resultado del Tratamiento , Úlcera/diagnóstico , Úlcera/epidemiología , Úlcera/etiología , Úlcera/psicología , Úlcera/cirugía , Vómitos/epidemiología , Vómitos/etiología
5.
Am Surg ; 71(5): 416-9, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15986973

RESUMEN

Tube thoracostomy management with suction or water seal after anatomical pulmonary resection remains somewhat controversial. Initial chest tube management may influence the duration of pleural fluid drainage, duration of tube thoracostomy, and/or hospital length of stay following pulmonary resection. We hypothesized that initial chest tube management with water seal decreases time for chest tube removal and decreases time of hospital stay. A retrospective chart review was performed on 109 consecutive patients who underwent lobectomy or segmentectomy in Western Pennsylvania Hospital between December 1999 and December 2003. Comparison was made between chest tube management of water seal or suction in patients with and without air leak. Of the 109 patients, 78 (72%) had no air leak at the completion of surgery, and 31 (28%) had air leak. In the group without air leak (n = 78), water seal was used in 32 (41%) patients and suction in 46 (59%). In patients placed to water seal initially after surgery (n = 32), removal of chest tubes was on postoperative day (POD) 3.19 +/- 0.24 and hospital discharge was on POD 5.13 +/- 0.61. In patients placed to suction initially (n = 46), chest tubes were removed on POD 4.52 +/- 0.40. Hospital discharge was on POD 6.74 +/- 0.5. Both duration of chest tube (P < 0.007) and length of hospital stay (P < 0.04) were significantly lower in the water seal group. In the air leak group (n = 31), 7 (23%) patients were managed with water seal and 24 (77%) patients with suction. Both duration of chest tube (P = 0.001) and length of hospital stay (P < 0.05) were significantly lower in the water seal group. In patients without air leak, chest tubes should be managed with water seal following anatomical pulmonary resection, resulting in significantly shorter chest tube duration and hospital length of stay.


Asunto(s)
Neumonectomía , Complicaciones Posoperatorias/prevención & control , Toracostomía , Adulto , Anciano , Anciano de 80 o más Años , Tubos Torácicos , Remoción de Dispositivos , Drenaje/métodos , Femenino , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/terapia , Estudios Retrospectivos , Succión/efectos adversos , Toracostomía/efectos adversos , Factores de Tiempo
6.
Cancer Genet Cytogenet ; 84(2): 91-4, 1995 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-8536228

RESUMEN

Acute promyelocytic leukemia (APL) is characterized by a specific t(15;17) translocation and a high rate of response to all-trans retinoic acid. The translocation generates a PML/RAR alpha chimeric gene which is transcribed in a fusion PML/RAR alpha mRNA. In this study, by using RT-PCR, we examined 14 APL patients for PML/RAR alpha fusion gene transcripts. Eight patients were studied at diagnosis, 2 at relapse, 1 both at relapse and after reinduction, 1 both at diagnosis and after three cycles of consolidation chemotherapy, and 2 patients were examined for minimal residual disease (MRD) 4 months after completing treatment. A positive result was observed in all 14 cases. Two patients who were in complete hematologic remission had evidence of hematologic relapse soon after the positive test. We conclude that RT-PCR for APL yields important diagnostic and prognostic information for the APL patients.


Asunto(s)
Leucemia Promielocítica Aguda/genética , Proteínas de Neoplasias/genética , Proteínas de Fusión Oncogénica/genética , Adolescente , Adulto , Anciano , Secuencia de Bases , Mapeo Cromosómico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa
7.
Leuk Lymphoma ; 44(6): 1071-4, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12854913

RESUMEN

The incidence of isolated extramedullary disease (EMD) following allogeneic hematopoietic stem cell transplant (allo-HSCT) for chronic myelogenous leukemia (CML) is not fully known. One review found the incidence of isolated myeloid EMD, or granulocytic sarcoma (GS), in an allo-HSCT treated CML/myelodysplastic subgroup to be just 0.22%. The incidence of lymphoid EMD in similar patients is extremely rare with only two cases reported in the literature. While the etiology of EMD in the post-transplant setting is not entirely clear, there may be inefficacy of immune surveillance function outside of the bone marrow cavity. Isolated CML GS following allo-HSCT carries a median interval to bone marrow relapse between 7 and 10 months and a median survival of 12 months. Less is known about lymphoid EMD. The treatment in these cases is ill defined with modalities ranging from involved field radiation to second allo-HSCT. We present a case of isolated pancreatic lymphoid EMD diagnosed 15 months after allo-HSCT for CML. Our patient was also treated with withdrawal of his immunosuppressive regimen. Unfortunately, at just over 4 months following pancreatic resection, he developed systemic relapse and died. While EMD can occur anywhere in the body, CML associated pancreatic EMD is not previously reported.


Asunto(s)
Leucemia Mielógena Crónica BCR-ABL Positiva/terapia , Enfermedades Pancreáticas/etiología , Trasplante de Células Madre/efectos adversos , Corticoesteroides/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Células de la Médula Ósea/patología , Resultado Fatal , Enfermedad Injerto contra Huésped/patología , Humanos , Inmunosupresores/uso terapéutico , Masculino , Persona de Mediana Edad , Pancreatectomía , Enfermedades Pancreáticas/patología , Enfermedades Pancreáticas/cirugía , Recurrencia , Trasplante Homólogo/efectos adversos
8.
Surg Endosc ; 16(7): 1106, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11988790

RESUMEN

Access to the gastric remnant and duodenum is lost after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Traditionally, a percutaneous transhepatic access to the common bile duct has been used to manage choledocholithiasis and duct strictures. We present a novel method of laparoscopic transgastric endoscopic retrograde cholangiopancreatography for managing a benign biliary stricture after a Roux-en-Y gastric bypass.


Asunto(s)
Colangiopancreatografia Retrógrada Endoscópica/métodos , Colestasis Extrahepática/cirugía , Enfermedades del Conducto Colédoco/cirugía , Derivación Gástrica/efectos adversos , Laparoscopía/métodos , Anastomosis en-Y de Roux/efectos adversos , Anastomosis en-Y de Roux/métodos , Colestasis Extrahepática/etiología , Enfermedades del Conducto Colédoco/etiología , Femenino , Derivación Gástrica/métodos , Humanos , Persona de Mediana Edad , Obesidad Mórbida/cirugía , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/cirugía
9.
Surg Endosc ; 17(3): 413-5, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12457212

RESUMEN

BACKGROUND: Roux-en-Y gastric bypass (RYGB) is considered the surgical procedure of choice for morbid obesity. Patients who fail to meet weight loss goals after restrictive or malabsorptive surgery can be offered revision. We present five cases in which prior open bariatric procedures were revised laparoscopically. PATIENTS: Five patients presented for laparoscopic revision having regained weight after initial success with prior bariatric surgery. RESULTS: Preoperative body mass index averaged 46 kg/m2. Average operative time was significantly longer (344 min) than we had experienced with 56 primary RYGB during the same 4-month period (206 min). In one patient, a stricture had developed at the gastrojejunostomy requiring endoscopic dilation. There were no other complications and no deaths. All the patients had lost weight at the 6-month follow-up assessment. CONCLUSIONS: Laparoscopic revision of failed open bariatric procedures, although requiring longer operative times than primary RYGB, can be performed safely in the hands of an experienced minimally invasive surgeon.


Asunto(s)
Gastroplastia/métodos , Laparoscopía , Obesidad Mórbida/cirugía , Adulto , Femenino , Humanos , Persona de Mediana Edad , Reoperación
10.
Surg Endosc ; 18(4): 655-9, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15026924

RESUMEN

BACKGROUND: The prevalence of irritable bowel syndrome (IBS) is higher among subjects with gastroesophageal reflux disease (GERD). This study aimed to assess the effect of IBS on the postoperative outcome of antireflux surgery. METHODS: For this study, 102 patients who underwent laparoscopic fundoplication were screened preoperatively for IBS with the Rome II criteria. There were 32 patients in the IBS group and 70 patients in the non-IBS group. Most of the patients (97%) (31 of 32 IBS and 68 of 70 non-IBS patients) had both pre- and postoperative IBS evaluation. A visual analog GERD-specific scoring scale was used to evaluate GERD symptoms prospectively. RESULTS: In both groups, GERD symptom scores were statistically improved postoperatively. Of the 31 IBS patients 25 (80.6%) showed a reduction in their symptoms below the Rome II criteria for IBS diagnosis postoperatively. CONCLUSION: Irritable bowel syndrome does not have a negative effect on the outcome of laparoscopic antireflux surgery. Surgical correction of GERD may improve the severity of irritable bowel symptoms.


Asunto(s)
Fundoplicación/métodos , Reflujo Gastroesofágico/cirugía , Síndrome del Colon Irritable/complicaciones , Laparoscopía/métodos , Adulto , Comorbilidad , Dispepsia/etiología , Trastornos de la Motilidad Esofágica/complicaciones , Femenino , Estudios de Seguimiento , Fundoplicación/estadística & datos numéricos , Reflujo Gastroesofágico/complicaciones , Humanos , Laparoscopía/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Satisfacción del Paciente , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Método Simple Ciego , Resultado del Tratamiento
11.
Surg Endosc ; 16(12): 1653-7, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12239643

RESUMEN

BACKGROUND: Morbid obesity has been described as a continuing epidemic affecting a growing portion of our population. We report an outcome analysis of our early experience with laparoscopic Roux-en-Y gastric bypass (LRYGB) in the treatment of morbid obesity. METHODS: Two surgeons performed 116 consecutive LRYGBs at a single institution, creating a 25-ml pouch and a 90- to 150-cm Roux limb. The prospectively collected data included patient demographics, comorbidities, postoperative weight loss, and complications. RESULTS: All eight conversions to an open procedure occurred early during the experience of the surgeons. The mean operating room time for the first 50 cases was 272 min, which decreased to 198 min with experience. The mean length of hospital stay was 3 days. There were 34 complications in 27 patients (23.3%), 14 of which (12%) required reoperation. At 18 months postoperatively, the patients had lost 77% of their excess weight, and their body mass index had decreased from a mean of 49.3 to 32.6 kg/m2. As a result of LRYGB, 25% of the patients were rendered completely free of any pharmacologic treatment for their preexisting comorbidities. CONCLUSIONS: Although technically challenging, LRYGB can be performed safely with excellent long-term results. The mean operating room time and conversion rate improved with experience. As this study showed, LRYGB achieves an excellent rate of weight loss and improvement in preoperative comorbidities with a minimal length of hospital stay and an acceptable complication rate.


Asunto(s)
Anastomosis en-Y de Roux/métodos , Derivación Gástrica/métodos , Laparoscopía/métodos , Obesidad Mórbida/cirugía , Adulto , Anciano , Anastomosis en-Y de Roux/efectos adversos , Anastomosis en-Y de Roux/mortalidad , Pérdida de Sangre Quirúrgica/estadística & datos numéricos , Femenino , Estudios de Seguimiento , Derivación Gástrica/efectos adversos , Derivación Gástrica/mortalidad , Humanos , Laparoscopía/efectos adversos , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/cirugía , Estudios Prospectivos , Reoperación/métodos , Factores de Tiempo , Resultado del Tratamiento , Pérdida de Peso
12.
Surg Endosc ; 18(3): 444-7, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-14752653

RESUMEN

BACKGROUND: Laparoscopic repair of paraesophageal hernia (LRPEH) is a feasible and effective technique. There have been some recent concerns regarding possible high recurrence rates following laparoscopic repair. METHODS: We reviewed our experience with LRPEH from 5/1996 to 8/2002. Large paraesophageal hernia (PEH) was defined by the presence of more than one-third of the stomach in the thoracic cavity. Principles of repair included reduction of the hernia, excision of the sac, approximation of the crura, and fundoplication. Pre- and postoperative symptoms were evaluated utilizing visual analogue scores (VAS) on a scale ranging from 0 to 10. Patients were followed with VAS and barium esophagram studies. Statistical analysis was performed using two-tailed Student's t-test. RESULTS: A total of 166 patients with a mean age of 68 years underwent LRPEH. PEH were type II ( n = 43), type III ( n = 104), and type IV ( n = 19). Mean operative time was 160 min. Fundoplications were Nissen (127), Toupet (23), Dor (1), and Nissen-Collis (1). Fourteen patients underwent a gastropexy. One patient required early reoperation to repair an esophageal leak. Mean hospital stay was 3.9 days. At 24 months postoperatively there was statistically significant improvement in the mean symptom scores: heartburn from 6.8 to 0.5, regurgitation from 5.9 to 0.3, dysphagia from 4.0 to 0.5, chest pain from 3.7 to 0.3. Radiographic surveillance was obtained in 120 patients (72%) at a mean of 15 months postoperatively. Six patients (5%) had radiographic evidence of a recurrent paraesophageal hernia (two required surgery), 24 patients (20%) had a sliding hernia (two required surgery), and four patients (3.3%) had wrap failure (all four required surgery). Reoperation was required in 10 patients (6%); two for symptomatic recurrent PEH (1.2%), four for recurrent reflux symptoms (2.4%), and four for dysphagia (2.4%). Patients with abnormal postoperative barium esophagram studies who did not require reoperation have remained asymptomatic at a mean follow up of 14 months. CONCLUSION: LPEHR is a safe and effective treatment for PEH. Postoperative radiographic abnormalities, such as a small sliding hernia, are often seen. The clinical importance of these findings is questionable, since only a small percentage of patients require reoperation. True PEH recurrences are uncommon and frequently asymptomatic.


Asunto(s)
Fundoplicación/métodos , Hernia Hiatal/cirugía , Laparoscopía/estadística & datos numéricos , Adulto , Anciano , Anciano de 80 o más Años , Bario , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/etiología , Medios de Contraste , Bases de Datos Factuales , Femenino , Estudios de Seguimiento , Fundoplicación/estadística & datos numéricos , Reflujo Gastroesofágico/epidemiología , Reflujo Gastroesofágico/etiología , Hernia Hiatal/complicaciones , Hernia Hiatal/diagnóstico por imagen , Hernia Hiatal/epidemiología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Pennsylvania , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Radiografía , Recurrencia , Reoperación/estadística & datos numéricos , Estudios Retrospectivos
13.
Surg Endosc ; 17(8): 1200-5, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12739117

RESUMEN

BACKGROUND: Recent reports have suggested that antireflux surgery should not be advised with the expectation of elimination of medical treatment. We reviewed our results with laparoscopic fundoplication as a means of eliminating the symptoms of gastroesophageal reflux disease (GERD), improving quality of life, and freeing patients from chronic medical treatment for GERD. METHODS: A total of 297 patients who underwent laparoscopic fundoplication (Nissen, n = 252; Toupet, n = 45) were followed for an average of 31.4 months. Preoperative evaluation included endoscopy, barium esophagram, esophageal manometry, and 24-h pH analysis. A preoperative and postoperative visual analogue scoring scale (0-10 severity) was used to evaluate symptoms of heartburn, regurgitation, and dysphagia. A GERD score (2-32) as described by Jamieson was also utilized. The need for GERD medications before and after surgery was assessed. RESULTS: At 2-year follow-up, the average symptom scores decreased significantly in comparison to the preoperative values: heartburn from 8.4 to 1.7, regurgitation from 7.2 to 0.7, and dysphagia from 3.7 to 1.0. The Jamieson GERD score also decreased from 25.7 preoperatively to 4.1 postoperatively. Only 10% of patients were on proton pump inhibitors (PPI) at 2 years after surgery for typical GERD symptoms. A similar percentage of patients (8.7%) were on PPI treatment for questionable reasons, such as Barrett's esophagus, "sensitive" stomach, and irritable bowel syndrome. Seventeen patients (5.7%) required repeat fundoplication for heartburn ( n = 9), dysphagia ( n = 5), and gas/bloating ( n = 3). CONCLUSIONS: Laparoscopic fundoplication can successfully eliminate GERD symptoms and improve quality of life. Significant reduction in the need for chronic GERD medical treatment 2 years after antireflux surgery can be anticipated.


Asunto(s)
Fundoplicación/métodos , Reflujo Gastroesofágico/cirugía , Laparoscopía , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antiácidos/uso terapéutico , Antiulcerosos/uso terapéutico , Antiespumantes/uso terapéutico , Terapia Combinada , Trastornos de Deglución/etiología , Femenino , Estudios de Seguimiento , Reflujo Gastroesofágico/complicaciones , Reflujo Gastroesofágico/tratamiento farmacológico , Reflujo Gastroesofágico/etiología , Antagonistas de los Receptores H2 de la Histamina/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Dolor/etiología , Presión , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
14.
Surg Endosc ; 17(4): 610-4, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12582772

RESUMEN

BACKGROUND: We reviewed our experience with complications following laparoscopic Roux-en-Y gastric bypass (LRYGB) that were managed laparoscopically. METHODS: A total of 246 consecutive morbidly obese patients (mean body mass index, 50.9 kg/m2) underwent LRYGB by three surgeons at two institutions. All patients met National Institutes of Health criteria for surgical treatment of morbid obesity. Patients were followed prospectively. RESULTS: A total of 62 patients (25.2%) developed 64 complications, 34 of which (13.8%) required a surgical intervention. Twenty-seven of the 34 procedures were performed laparoscopically. Gastrojejunostomy stricture was the most common complication (8.9%), followed by intestinal obstruction (7.3%) and gastrointestinal bleeding (4%). The intestinal obstruction was secondary to adhesions (n = 6), internal hernia at the level of the transverse mesocolon (n = 3), jejunojejunostomy stricture (n = 3), and cicatrix around the Roux limb at the level of the transverse mesocolon (n = 3). Other complications included gastrojejunostomy leak (1.6%), symptomatic gallstone disease (2.8%), and gastric remnant perforation (0.8%). One patient underwent a negative laparoscopy to rule out anastomotic leak. There were 3 deaths in this series of patients, 2 attributable to anastomotic leak. CONCLUSIONS: A variety of complications can present after LRYGB. Laparoscopy is an excellent technique to treat these complications.


Asunto(s)
Anastomosis en-Y de Roux/efectos adversos , Derivación Gástrica/efectos adversos , Laparoscopía , Obesidad Mórbida/cirugía , Complicaciones Posoperatorias , Adulto , Anastomosis en-Y de Roux/métodos , Índice de Masa Corporal , Femenino , Derivación Gástrica/métodos , Humanos , Laparoscopía/efectos adversos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
15.
Surg Endosc ; 17(3): 381-5, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12457222

RESUMEN

BACKGROUND: Postoperative gas/bloating (G/B) is a common sequelae after laparoscopic fundoplication. Patients with "upright" reflux are thought to have more aerophagic tendencies contributing to their GERD symptoms than patients with significant "supine" patterns of reflux. The risk of postoperative G/B developing was analyzed in relation to patient preoperative patterns of upright, mixed, or supine 24-h pH scores. METHODS: In this study, 339 patients undergoing fundoplication (278 Nissen and 61 Toupet) were evaluated for preoperative G/B symptoms using a 0 to 10 severity visual analogue scale. Reflux patterns were classified as upright, supine, or mixed according to 24-h pH studies. RESULTS: As compared with preoperative values, 46% of the patients with a preoperative G/B score less than 3 and an upright or mixed reflux pattern had a significant increase in their average G/B score at 2 years (upright, from 0.9 to 4.2; mixed, from 1.1 to 4.1). However, the patients with a supine reflux pattern did not have a statistically significant change (from 2.0 to 2.2; p > 0.05). The patients with established aerophagic tendencies preoperatively (G/B score > 3) showed significant improvement in these symptoms at 2 years across all three reflux patterns (average G/B score, from 7.7 preoperatively to 4.8 at 2 years). There was no gender predisposition, nor was there any difference in the incidence of G/B between complete and partial fundoplication. CONCLUSIONS: The pattern of 24-h acid reflux can be predictive of G/B after antireflux surgery. Patients with mild preoperative G/B symptoms (score <3) and upright or mixed patterns of 24-h acid reflux appear to have an increased postoperative risk for chronic G/B as compared with patients who have supine reflux and mild preoperative G/B. Patients with moderate to severe preoperative G/B symptoms (score, 3-10) appear to have a general improvement in G/B symptoms at 2 years after fundoplication.


Asunto(s)
Fundoplicación/efectos adversos , Gases , Reflujo Gastroesofágico/cirugía , Intestinos , Laparoscopía/efectos adversos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Fundoplicación/métodos , Reflujo Gastroesofágico/etiología , Humanos , Concentración de Iones de Hidrógeno , Masculino , Persona de Mediana Edad , Monitoreo Fisiológico , Postura
16.
Surg Endosc ; 18(11): 1636-9, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15931474

RESUMEN

BACKGROUND: Standard therapy for abdominal compartment syndrome (ACS) is laparotomy and temporary abdominal wall closure with significant morbidity. The component separation technique allows for difficult abdominal closure. We studied a modified extraperitoneal endoscopic separation of parts technique on an animal model of ACS. METHODS: Twelve anesthetized pigs were instrumented for measurement of central venous pressure, arterial pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac output, and intraabdominal pressure (IAP). ACS to 25 mmHg was created by infusing saline into an intraabdominally placed bag. Animals were divided in two equal groups. Pigs in group A underwent minimally invasive resection of the nerves supplying the rectus muscles bilaterally. Pigs in group B underwent minimally invasive modified component separation technique bilaterally. Change in IAP and other physiological parameters were recorded. RESULTS: (Group A) IAP increased significantly from 7.3 mmHg +/- 3.8 to 25.2 mmHg +/- 1.5 with infusion of saline. Following nerve transection on the right side there was a nonsignificant decrease in IAP from 25.2 mmHg +/- 1.5 to 22.3 mmHg +/- 1.4 and following nerve transection on the left side there was a further decrease in IAP to 20.3 mmHg +/- 1.9. (Group B) IAP increased significantly from 3.8 mmHg +/- 0.4 to 24.7 mmHg +/- 0.5 with infusion of saline. Following separation of parts on the right side there was a significant decrease in IAP from 24.7 mmHg +/- 0.5 to 15.0 mmHg +/- 1.7 and there was a further decrease in IAP to 11.3 mmHg +/- 1.4 following separation of parts on the left side. The only significant change in the physiological parameters measured was observed in CVP in both groups. CONCLUSION: We present a porcine model of extraperitoneal endoscopic release of abdominal wall components as a treatment option for ACS.


Asunto(s)
Abdomen , Síndromes Compartimentales/cirugía , Endoscopía/métodos , Animales , Presión , Porcinos
19.
Ann Burns Fire Disasters ; 20(1): 22-4, 2007 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-21991062

RESUMEN

Tourniquets are routinely used during the excising and grafting of burn wounds located on the limbs in order to decrease blood loss. It has been postulated that the exsanguination of extremities by using Esmarch bandages might further reduce blood loss. However, there are concerns about a decrease in graft quality when Esmarch bandages are applied. The purpose of this prospective, double-blinded randomized study was to compare Esmarch application in addition to tourniquet (exsanguinated extremities) with the application of tourniquet alone. Thirty-eight excisions of bilateral extremity wounds were performed. Both limbs were tangentially excised after tourniquet application with one limb randomly chosen for prior Esmarch exsanguination. Blood loss was estimated during this procedure. Graft take was assessed twice: on post-operative days 3 and 7. The burn surface area and total area grafted were equivalent in the extremities with Esmarch bandages when compared to the extremities without them. Total blood loss was less in the extremities where Esmarch was applied. Graft take was similar in the two groups. Statistical analysis was performed with a two-tailed paired T-test. It is concluded that the use of Esmarch exsanguination in addition to tourniquet further reduces blood loss without affecting the quality of the engraftment.

20.
Int J Gynecol Cancer ; 16 Suppl 1: 299-303, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16515608

RESUMEN

Sternal and costal metastases from ovarian cancer are extremely rare. We present here a case of a 47-year-old woman with thoracic wall metastasis from serous-papillary ovarian carcinoma that occurred 3 years after the initial diagnosis, although the patient had received various regimens of intense platinum-based chemotherapy. Special emphasis is given to the effects of alkylating agents, such as cisplatin and carboplatin, on the pattern of tumor spread. We also discuss the possible mechanisms through which the biologic and metastatic behavior of this tumor is expressed.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Neoplasias Óseas/tratamiento farmacológico , Carboplatino/administración & dosificación , Cisplatino/administración & dosificación , Cistadenocarcinoma Papilar/tratamiento farmacológico , Neoplasias Ováricas/tratamiento farmacológico , Neoplasias Óseas/secundario , Neoplasias Óseas/terapia , Terapia Combinada , Cistadenocarcinoma Papilar/secundario , Cistadenocarcinoma Papilar/terapia , Desoxicitidina/administración & dosificación , Desoxicitidina/análogos & derivados , Docetaxel , Epirrubicina/administración & dosificación , Femenino , Procedimientos Quirúrgicos Ginecológicos , Humanos , Persona de Mediana Edad , Recurrencia Local de Neoplasia/terapia , Estadificación de Neoplasias , Neoplasias Ováricas/patología , Neoplasias Ováricas/terapia , Paclitaxel/administración & dosificación , Costillas , Esternón , Taxoides/administración & dosificación , Pared Torácica , Topotecan/administración & dosificación , Resultado del Tratamiento , Vinblastina/administración & dosificación , Vinblastina/análogos & derivados , Vinorelbina , Gemcitabina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA